Monthly Archives: July 2013

Belviq®: A Novel Multipotential Therapeutic and Preventative Anti-Obesity Medication

Belviq® is an anti-obesity drug, but it also potentially helps with treating Type 2 Diabetes (Diabetes Mellitus) and other co-morbidities, including metabolic syndrome (abdominal obesity, hyperglycemia, dyslipidemia, and hypertension).  Belviq® also potentially improves many other indications, including asthma and smoking cessation (nicotine addiction).

http://beta.fool.com/bruinmd/2012/09/27/belviq-novel-diamond-ruff-treatment-obesity-and-re/12601/

Patient Testimonial from mbenjam2

Just as a reminder I am a Type 1 diabetic which is important for all diabetics (Type 1 and 2) as well as pre-diabetics who can benefit from Belviq as well:

22 Days in:

Starting weight: 202 Pounds 22 days into useage (this AM 188 Pounds)

Insulin Usage: Starting 30 Units 4 times daily. 15 days into usage 18 Units 4 times daily. My waking Blood Sugar this AM was at 110. I am monitoring just before my bedtime shot.

The decrease in my insulin costs are now saving me the cost of the Belviq as Insulin is twice the cost. – mbenjam2